Skip to main content
. 2021 Aug 19;6:310. doi: 10.1038/s41392-021-00723-z

Fig. 1.

Fig. 1

a In a salvage pathway nicotinamide ribose (NR) and/or nicotinamide (NAM) are converted to nicotinamide mononucleotide (NMN), which is the precursor of nicotinamide adenine dinucleotide (NAD+). NAD+ is involved in a spectrum of diseases. b Postmenopausal prediabetic women with overweight or obesity were treated with NMN or placebo for 10 weeks and muscle biopsies revealed, c increased muscle NAD+ turnover, insulin sensitivity, phosphorylation of mTOR and Akt, and a gene expression involving the PDGF-binding pathway in NMN-treated participants as compared to control. d Open questions, however, remain to fully assess the mechanism of NMN in mediating muscle insulin sensitivity. Furthermore, potential long-term side effects should be considered. The figure was generated with Biorender.com.